Overview Dividends

(CPB) Campbell’s - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1344291091

Soups, Sauces, Broths, Cookies, Crackers, Chips

CPB EPS (Earnings per Share)

EPS Growth (3Y CAGR): -59.35%
EPS Trend (3Y Correlation): -44.8%

CPB Revenue

Revenue Growth (3Y CAGR): -3.71%
Revenue Trend (3Y Correlation): 19.8%

Description: CPB Campbell’s November 04, 2025

The Campbell’s Company (NYSE: CPB) manufactures and markets a broad portfolio of food and beverage brands across two segments-Meals & Beverages and Snacks-serving retail and food-service channels in the United States, Canada, and Latin America. The Meals & Beverages segment includes iconic items such as Campbell’s soups, Swanson broths, V8 juices, and Pacific Foods plant-based beverages, while the Snacks segment houses Pepperidge Farm cookies, Goldfish crackers, Kettle Brand chips, and Snyder’s pretzels, among others.

Key recent metrics: CPB reported FY 2023 net sales of roughly $5.7 billion, with the Snacks segment delivering a 4.5 % higher contribution margin than the Meals & Beverages segment, reflecting a strategic shift toward higher-margin, on-the-go products. Inflation-driven input-cost volatility and a consumer tilt toward healthier, plant-based options remain primary economic drivers for the business; CPB’s acquisition of Pacific Foods in 2020 positions it to capture growth in the “better-for-you” category, which the packaged-foods industry is seeing a 6-7 % CAGR in North America. Additionally, the company’s exposure to private-label competition in mass discounters adds execution risk to its pricing power.

If you want to explore CPB’s valuation sensitivities, cash-flow projections, and peer-group benchmarks in more depth, ValueRay’s analytics platform offers a convenient way to continue the research.

CPB Stock Overview

Market Cap in USD	8,970m
Sub-Industry	Packaged Foods & Meats
IPO / Inception	1985-07-01

CPB Stock Ratings

Growth Rating	-65.2%
Fundamental	55.7%
Dividend Rating	50.6%
Return 12m vs S&P 500	-44.1%
Analyst Rating	3.13 of 5

CPB Dividends

Dividend Yield 12m	5.24%
Yield on Cost 5y	3.86%
Annual Growth 5y	1.40%
Payout Consistency	72.3%
Payout Ratio	52.4%

CPB Growth Ratios

Growth Correlation 3m	-65.7%
Growth Correlation 12m	-90.9%
Growth Correlation 5y	-17%
CAGR 5y	-13.79%
CAGR/Max DD 3y (Calmar Ratio)	-0.33
CAGR/Mean DD 3y (Pain Ratio)	-0.67
Sharpe Ratio 12m	-1.34
Alpha	-37.85
Beta	0.023
Volatility	22.01%
Current Volume	3512k
Average Volume 20d	4828.6k
Stop Loss	28.8 (-3.3%)
Signal	-0.40

Piotroski VR‑10 (Strict, 0-10) 2.5

Net Income (602.0m TTM) > 0 and > 6% of Revenue (6% = 615.2m TTM)

FCFTA 0.05 (>2.0%) and ΔFCFTA 0.43pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue -6.57% (prev -14.38%; Δ 7.81pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.08 (>3.0%) and CFO 1.14b > Net Income 602.0m (YES >=105%, WARN >=100%)

Net Debt (7.08b) to EBITDA (1.56b) ratio: 4.54 <= 3.0 (WARN <= 3.5)

Current Ratio 0.77 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (299.0m) change vs 12m ago 0.34% (target <= -2.0% for YES)

Gross Margin 30.42% (prev 30.83%; Δ -0.41pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 68.06% (prev 63.25%; Δ 4.81pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 3.26 (EBITDA TTM 1.56b / Interest Expense TTM 345.0m) >= 6 (WARN >= 3)

Altman Z'' 1.68

(A) -0.05 = (Total Current Assets 2.23b - Total Current Liabilities 2.91b) / Total Assets 14.90b

(B) 0.32 = Retained Earnings (Balance) 4.69b / Total Assets 14.90b

(D) 0.43 = Book Value of Equity 4.69b / Total Liabilities 10.99b

Total Rating: 1.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 55.65

1. Piotroski 2.50pt = -2.50

2. FCF Yield 4.47% = 2.23

3. FCF Margin 6.99% = 1.75

4. Debt/Equity 1.85 = 1.00

5. Debt/Ebitda 4.54 = -2.50

6. ROIC - WACC (= 4.11)% = 5.14

7. RoE 15.51% = 1.29

8. Rev. Trend 19.76% = 1.48

9. EPS Trend -44.78% = -2.24

What is the price of CPB shares?

As of November 05, 2025, the stock is trading at USD 29.79 with a total of 3,512,007 shares traded.
Over the past week, the price has changed by -3.72%, over one month by -4.79%, over three months by -6.60% and over the past year by -32.89%.

Is Campbell’s a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Campbell’s is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 55.65 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CPB is around 27.19 USD . This means that CPB is currently overvalued and has a potential downside of -8.73%.

Is CPB a buy, sell or hold?

Campbell’s has received a consensus analysts rating of 3.13. Therefor, it is recommend to hold CPB.

Strong Buy: 4
Buy: 2
Hold: 12
Sell: 3
Strong Sell: 2

What are the forecasts/targets for the CPB price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	34.5	15.7%
Analysts Target Price	34.5	15.7%
ValueRay Target Price	29	-2.6%

CPB Fundamental Data Overview November 01, 2025

Market Cap USD = 8.97b (8.97b USD * 1.0 USD.USD)
P/E Trailing = 14.99
P/E Forward = 12.7389
P/S = 0.8748
P/B = 2.4133
P/EG = 0.6736
Beta = 0.023
Revenue TTM = 10.25b USD
EBIT TTM = 1.12b USD
EBITDA TTM = 1.56b USD
Long Term Debt = 6.06b USD (from longTermDebt, last quarter)
Short Term Debt = 858.0m USD (from shortTermDebt, last quarter)
Debt = 7.21b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.08b USD (from netDebt column, last quarter)
Enterprise Value = 16.05b USD (8.97b + Debt 7.21b - CCE 132.0m)
Interest Coverage Ratio = 3.26 (Ebit TTM 1.12b / Interest Expense TTM 345.0m)
FCF Yield = 4.47% (FCF TTM 717.0m / Enterprise Value 16.05b)
FCF Margin = 6.99% (FCF TTM 717.0m / Revenue TTM 10.25b)
Net Margin = 5.87% (Net Income TTM 602.0m / Revenue TTM 10.25b)
Gross Margin = 30.42% ((Revenue TTM 10.25b - Cost of Revenue TTM 7.13b) / Revenue TTM)
Gross Margin QoQ = 30.37% (prev 29.41%)
Tobins Q-Ratio = 1.08 (Enterprise Value 16.05b / Total Assets 14.90b)
Interest Expense / Debt = 1.18% (Interest Expense 85.0m / Debt 7.21b)
Taxrate = 21.20% (39.0m / 184.0m)
NOPAT = 885.8m (EBIT 1.12b * (1 - 21.20%))
Current Ratio = 0.77 (Total Current Assets 2.23b / Total Current Liabilities 2.91b)
Debt / Equity = 1.85 (Debt 7.21b / totalStockholderEquity, last quarter 3.90b)
Debt / EBITDA = 4.54 (Net Debt 7.08b / EBITDA 1.56b)
Debt / FCF = 9.87 (Net Debt 7.08b / FCF TTM 717.0m)
Total Stockholder Equity = 3.88b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.04% (Net Income 602.0m / Total Assets 14.90b)
RoE = 15.51% (Net Income TTM 602.0m / Total Stockholder Equity 3.88b)
RoCE = 11.31% (EBIT 1.12b / Capital Employed (Equity 3.88b + L.T.Debt 6.06b))
RoIC = 7.91% (NOPAT 885.8m / Invested Capital 11.20b)
WACC = 3.80% (E(8.97b)/V(16.18b) * Re(6.10%) + D(7.21b)/V(16.18b) * Rd(1.18%) * (1-Tc(0.21)))
Discount Rate = 6.10% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 0.0 | Cagr: 0.0%
[DCF Debug] Terminal Value 77.66% ; FCFE base≈697.4m ; Y1≈668.9m ; Y5≈652.8m
Fair Price DCF = 39.11 (DCF Value 11.64b / Shares Outstanding 297.7m; 5y FCF grow -5.44% → 3.0% )
EPS Correlation: -44.78 | EPS CAGR: -59.35% | SUE: -4.0 | # QB: 0
Revenue Correlation: 19.76 | Revenue CAGR: -3.71% | SUE: -0.56 | # QB: 0

Additional Sources for CPB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle